EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

NEURO-ONCOLOGY AND TARGETED THERAPIES FOR GLIOBLASTOMA

Wesam Taher Almagharbeh, Abdul Ghaffar

Gomal Journal of Life Sciences · 30.06.2024 · 2 (01) · 87-106

DOI: 10.66406/gjls0135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gomal Journal of Life Sciences, online erschienen am 30.06.2024. Verfasst von Wesam Taher Almagharbeh und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Due to its nonresponsiveness to standard therapy, cellular diversity, and advanced growth rate, glioblastoma multiforme (GBM) is a great clinical problem. The research adopted a mixed-methods study that enrolled 120 GBM patients stratified into standard and targeted treatment groups to evaluate the effectiveness of the targeted medical techniques in the combination with neuro-oncology standards. The quantitative outcomes included MRI volumetrics, progression-free survival (PFS) and molecular biomarker dynamics measured using digital droplet PCR and next generation sequencing tools. Having achieved mean tumor volume reduction of 22% after three treatment courses, targeted therapies, namely, bevacizumab, EGFR inhibitors, and IDH1 modulators, showed a statistically significant improvement in PFS (p < 0.01). The responders had a stronger response towards treatment and a low rate of recurrence as seen with molecular responders; mostly on IDH 1 mutation and methylated MGMT promoter molecules. It was also found that the specific population has experienced a positive impact in terms of treatment satisfaction, emotional coping, and cognitive clarity during qualitative interviews with patients and caregivers. Thematic analysis confirmed that integrated care models proffered a disease pathway that was more dignified and manageable. On balance, this paper identifies that patient-centered and precision-driven care plays a decisive role in the treatment of GBM and provides a standardizable methodological scheme of further translation studies in neuro-oncology.

Zitieren

APA

Almagharbeh, W. T., & Ghaffar, A. (2024). NEURO-ONCOLOGY AND TARGETED THERAPIES FOR GLIOBLASTOMA. Gomal Journal of Life Sciences, 2(01), 87-106. https://doi.org/10.66406/gjls0135

Vancouver

Almagharbeh WT, Ghaffar A. NEURO-ONCOLOGY AND TARGETED THERAPIES FOR GLIOBLASTOMA. Gomal Journal of Life Sciences. 2024;2(01):87-106. doi:10.66406/gjls0135

BibTeX
@article{Almagharbeh2024,
  author = {Almagharbeh, Wesam Taher and Ghaffar, Abdul},
  title = {NEURO-ONCOLOGY AND TARGETED THERAPIES FOR GLIOBLASTOMA},
  journal = {Gomal Journal of Life Sciences},
  year = {2024},
  volume = {2},
  number = {01},
  pages = {87--106},
  doi = {10.66406/gjls0135}
}
Kostenlos starten →